Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.32 USD | +0.22% | -25.50% | +12.42% |
09/05 | Cantor Fitzgerald Adjusts LifeMD's Price Target to $15 From $13, Keeps Overweight Rating | MT |
08/05 | Transcript : LifeMD, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.42% | 380M | |
+5.85% | 32.95B | |
+20.16% | 8.09B | |
+30.81% | 4B | |
-25.95% | 3.09B | |
-19.96% | 1.39B | |
-31.87% | 1.19B | |
+8.02% | 966M | |
-35.73% | 933M | |
-25.74% | 834M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- B. Riley Raises LifeMD's Price Target to $11 From $7 After Q3 Topline Beat, Maintains Buy Rating